WEEKLY BORTEZOMIB FOR THE TREATMENT OF STEROID REFRACTORY CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD)

被引：1
|
作者：
Miller, A. M. [1 ]
Schneider, R. [1 ]
Agura, E. A. [1 ]
Vance, E. [1 ]
Bergman, R. B. [1 ]
Fay, J. [1 ]
Pineiro, L. [1 ]
Powell, S. [1 ]
Ovcina, Tadic M. [1 ]
Sampson, C. A. [1 ]
机构：
[1] Baylor Charles A Sammons Canc Ctr, Dallas, TX USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2011年 / 17卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2010.12.567
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
530
引用
收藏
页码：S343 / S343
页数：1
相关论文
共 50 条
  • [41] VEDOLIZUMAB IN STEROID REFRACTORY INTESTINAL GRAFT-VERSUS-HOST DISEASE
    Myhre, A. E.
    Kristiansen, J. D.
    Lundin, K. E. A.
    Osnes, L. T. N.
    Warren, D. J.
    Tjonnfjord, G. E.
    Gedde-Dahl, T.
    Floisand, Y.
    HAEMATOLOGICA, 2017, 102 : 611 - 612
  • [42] Tocilizumab for steroid refractory acute graft-versus-host disease
    Roddy, Julianna V. F.
    Haverkos, Bradley M.
    McBride, Ali
    Leininger, Kathryn M.
    Jaglowski, Samantha
    Penza, Sam
    Klisovic, Rebecca
    Blum, William
    Vasu, Sumithira
    Hofmeister, Craig C.
    Benson, Don M.
    Andritsos, Leslie A.
    Devine, Steven M.
    Efebera, Yvonne A.
    LEUKEMIA & LYMPHOMA, 2016, 57 (01) : 81 - 85
  • [43] Extracorporeal photopheresis in acute and chronic steroid‑refractory graft-versus-host disease: an evolving treatment landscape
    Hildegard T. Greinix
    Francis Ayuk
    Robert Zeiser
    Leukemia, 2022, 36 : 2558 - 2566
  • [44] Treatment of steroid-refractory acute and chronic graft-versus-host disease with ruxolitinib in adults and children
    Moiseev, Ivan
    Morozova, Elena
    Barabanshikova, Maria
    Kozlov, Andrey
    Rudakova, Tatyana
    Klimova, Olesya
    Tcvetkov, Nikolai
    Pirogova, Olga
    Borzenkova, Evgeniya
    Kozhokar, Polina
    Ekushev, Kirill
    Paina, Olesya
    Bykova, Tatyana
    Darskaya, Elena
    Bondarenko, Sergey
    Zubarovskaya, Ludmila
    Afanasyev, Boris
    BONE MARROW TRANSPLANTATION, 2018, 53 : 461 - 462
  • [45] Murine Models of Steroid Refractory Graft-versus-Host Disease
    Tomomi Toubai
    Corinne Rossi
    Isao Tawara
    Chen Liu
    Cynthia Zajac
    Katherine Oravecz-Wilson
    Daniel Peltier
    Yaping Sun
    Hideaki Fujiwara
    Shin-Rong Wu
    Mary Riwes
    Israel Henig
    Stephanie Kim
    Pavan Reddy
    Scientific Reports, 8
  • [46] Murine Models of Steroid Refractory Graft-versus-Host Disease
    Toubai, Tomomi
    Rossi, Corinne
    Tawara, Isao
    Liu, Chen
    Zajac, Cynthia
    Oravecz-Wilson, Katherine
    Peltier, Daniel
    Sun, Yaping
    Fujiwara, Hideaki
    Wu, Shin-Rong
    Riwes, Mary
    Henig, Israel
    Kim, Stephanie
    Reddy, Pavan
    SCIENTIFIC REPORTS, 2018, 8
  • [47] Once weekly extracorporale photopheresis for treatment of steroid-refractory or relapsed chronic graft versus host disease
    Ayuk, F.
    Christopeit, M.
    Guellstorf, M.
    Lellek, H.
    Wolbers, T.
    Von Pein, U. -M.
    Wolschke, C.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S175 - S176
  • [48] Hedgehog blockade in steroid-refractory sclerotic chronic graft-versus-host disease
    Radojcic, Vedran
    Pletneva, Maria
    Lee, Catherine J.
    Ivcevic, Sanja
    Sarantopoulos, Stefanie
    Couriel, Daniel
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (02) : E120 - E122
  • [49] The effect of mycophenolate mofetil in steroid refractory or dependent chronic graft-versus-host disease
    Soydan, EA
    Arat, M
    Topcuoglu, P
    Ozcan, M
    Arslan, O
    Idilman, R
    Gurman, G
    Beksac, M
    Akan, H
    Ilhan, O
    BONE MARROW TRANSPLANTATION, 2003, 31 : S135 - S136
  • [50] Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease
    M Okamoto
    A Okano
    S Akamatsu
    E Ashihara
    T Inaba
    H Takenaka
    N Katoh
    S Kishimoto
    C Shimazaki
    Leukemia, 2006, 20 : 172 - 173
12345